Neonatal neurobehavior effects following buprenorphine versus methadone exposure.
about
Maintenance agonist treatments for opiate-dependent pregnant womenNeonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects.Developmental consequences of fetal exposure to drugs: what we know and what we still must learnDepression-like effect of prenatal buprenorphine exposure in rats.Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review.The Roles of Maternal Depression, Serotonin Reuptake Inhibitor Treatment, and Concomitant Benzodiazepine Use on Infant Neurobehavioral Functioning Over the First Postnatal Month.Epigenetic Regulation of Placental NR3C1: Mechanism Underlying Prenatal Programming of Infant Neurobehavior by Maternal Smoking?The use of central nervous system active drugs during pregnancy.Placental HTR2A methylation is associated with infant neurobehavioral outcomes.Buprenorphine use in pregnant opioid users: a critical review.Brief review: Obstetric care and perioperative analgesic management of the addicted patient.Growth and developmental outcome of infants with in-utero exposure to methadone vs buprenorphine.Consequences of prenatal opioid use for newborns.Pharmacological Management of Opioid Use Disorder in Pregnant Women.Maternal Opioid Treatment: Human Experimental Research (MOTHER) Study: maternal, fetal and neonatal outcomes from secondary analyses.Prenatal Opioid Exposure and Intermittent Hypoxemia in Preterm Infants: A Retrospective Assessment.Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus.Neonatal abstinence syndrome: Neurobehavior at 6 weeks of age in infants with or without pharmacological treatment for withdrawal.Executive function in preschool children prenatally exposed to methadone or buprenorphine.
P2860
Q24201642-11D4BE69-04C2-4341-AEE2-4FBBA6729CD2Q30249670-E9C1ABC3-05E8-4A73-8C0F-A2C3401B4790Q30395013-F45C584E-33B1-4930-A27A-0F8720DBB038Q35075284-BC3003A1-1A23-4944-92CD-DF18F68447D8Q35863900-C2406BFB-8AC4-44C6-92EA-58DFC0FB5520Q36547279-7B9B1098-6A01-42F3-8C6B-7AAD2158619AQ36731071-6EEE5721-63E5-48D9-B2AA-530FD0722024Q37280003-73FE0DC5-141B-481D-94E5-92B52F2FF208Q37445268-CEB658D1-1F1C-42BA-AA9B-76A56EE8FB70Q38115201-E568A0FE-DE01-462A-BE9E-04768D668208Q38171337-9A1CF826-C76E-4363-AA15-D8651FECDB13Q38402261-F4D3FA03-A1A0-477A-9338-FCF59C028F58Q38547160-04083E22-0EE0-4ECD-A3DD-DB203E5CF36AQ38575591-7E0B1CB2-7318-4B36-8FAA-78F9B1F184EAQ44336585-6F7C1B47-7566-4328-BF88-BB45F2A676EDQ47114259-D47C3307-8B02-47FF-BCF2-DAC6C5F532B0Q47569876-3F2EA04A-A13A-49A2-8719-14C9CFCD3A84Q48351317-F28F9CA8-2267-4794-AF1C-B50ACAE6F751Q50626128-89E2C61A-0F86-48D6-9128-A1EF42297FA4
P2860
Neonatal neurobehavior effects following buprenorphine versus methadone exposure.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Neonatal neurobehavior effects following buprenorphine versus methadone exposure.
@ast
Neonatal neurobehavior effects following buprenorphine versus methadone exposure.
@en
type
label
Neonatal neurobehavior effects following buprenorphine versus methadone exposure.
@ast
Neonatal neurobehavior effects following buprenorphine versus methadone exposure.
@en
prefLabel
Neonatal neurobehavior effects following buprenorphine versus methadone exposure.
@ast
Neonatal neurobehavior effects following buprenorphine versus methadone exposure.
@en
P2093
P2860
P1433
P1476
Neonatal neurobehavior effects following buprenorphine versus methadone exposure.
@en
P2093
Amy L Salisbury
Gabriele Fischer
Klaudia Graf-Rohrmeister
Mara G Coyle
P2860
P356
10.1111/J.1360-0443.2012.04040.X
P407
P478
107 Suppl 1
P577
2012-11-01T00:00:00Z